320P First-line therapy (1L) of cisplatin/gemcitabine (CisGem) with pembrolizumab (pembro) in patients with advanced biliary tract cancer (aBTC): Open-label, single-arm phase II EORTC-1607-GITCG/ABC-09 intergroup study with translational research (TR)
Title:
320P First-line therapy (1L) of cisplatin/gemcitabine (CisGem) with pembrolizumab (pembro) in patients with advanced biliary tract cancer (aBTC): Open-label, single-arm phase II EORTC-1607-GITCG/ABC-09 intergroup study with translational research (TR)
Author:
Moehler, M. Maderer, A. Wagner, D.C. McNamara, M.G. Bridgewater, J.A. Arora, A. Mercade, T. Macarulla Adeva, J.A. Hubner, R. Lordick, F. Foerster, F. Weinmann, A. Galle, P.R. Leurquin, B. Marreaud, S.I. Mauer, M.E. Valle, J.W. Lamarca, A.